The invention relates to an anti-hypercholesterolemia composition and a method of manufacturing the composition. Accordingly, the present invention discloses the composition to lower the cholesterol formation and a method of manufacturing the same. The anti-hypercholesterolemia composition comprises Basella alba leaf extract in the range of 30 to 70 wt %, red yeast rice extract in the range of 5 to 50 wt %, squalene extract in the range of 1 to 30 wt %, Cordyceps extract in the range of 10 to 70 wt % and at least one nutraceutically or pharmaceutically acceptable excipient in the range of 0.01 to 50 wt %.

The invention relates to an anti-hypercholesterolemia composition and a method of manufacturing the composition. Accordingly, the present invention discloses the composition to lower the cholesterol formation and a method of manufacturing the same. The anti-hypercholesterolemia composition comprises Basella alba leaf extract in the range of 30 to 70 wt %, red yeast rice extract in the range of 5 to 50 wt %, squalene extract in the range of 1 to 30 wt %, Cordyceps extract in the range of 10 to 70 wt % and at least one nutraceutically or pharmaceutically acceptable excipient in the range of 0.01 to 50 wt %.

The invention relates to an anti-hypercholesterolemia composition and a method of manufacturing the composition. Accordingly, the present invention discloses the composition to lower the cholesterol formation and a method of manufacturing the same. The anti-hypercholesterolemia composition comprises Basella alba leaf extract in the range of 30 to 70 wt %, red yeast rice extract in the range of 5 to 50 wt %, squalene extract in the range of 1 to 30 wt %, Cordyceps extract in the range of 10 to 70 wt % and at least one nutraceutically or pharmaceutically acceptable excipient in the range of 0.01 to 50 wt %.

A method for treating coronavirus infection and bacterial infection in a subject in need thereof, including: applying to the subject a topical solution containing a therapeutically effective amount of Phyllanthus urinaria (PU) extract or one of its physiologically acceptable forms; and administering to the subject a composition comprising a therapeutically effective amount of Houttuynia cordata (HC) extract or one of its physiologically acceptable forms.

Methods for isolating bioactive components from Eurycoma longifolia (Tongkat Ali) are described. In one aspect, the methods comprise concentrating a solution comprising Eurycoma longifolia extract by a continuous-flow evaporation process. Extracts of Eurycoma longifolia and compositions comprising Eurycoma longifolia extract and uses thereof are also provided. The extracts and the compositions are useful for increasing testosterone levels and supporting natural stamina, endurance and strength.

Methods for isolating bioactive components from Eurycoma longifolia (Tongkat Ali) are described. In one aspect, the methods comprise concentrating a solution comprising Eurycoma longifolia extract by a continuous-flow evaporation process. Extracts of Eurycoma longifolia and compositions comprising Eurycoma longifolia extract and uses thereof are also provided. The extracts and the compositions are useful for increasing testosterone levels and supporting natural stamina, endurance and strength.

Methods for isolating bioactive components from Eurycoma longifolia (Tongkat Ali) are described. In one aspect, the methods comprise concentrating a solution comprising Eurycoma longifolia extract by a continuous-flow evaporation process. Extracts of Eurycoma longifolia and compositions comprising Eurycoma longifolia extract and uses thereof are also provided. The extracts and the compositions are useful for increasing testosterone levels and supporting natural stamina, endurance and strength.

Compositions and methods are provided for the treatment of a variety of inflammatory disease processes. The compositions generally comprise at least one edible or medicinal mushroom or extract thereof, at least one cannabinoid, at least one terpene, a curcumoinoid, and at least one flavonoid. Methods for optimizing compositions using artificial intelligence algorithms are also provided.

Compositions and methods are provided for the treatment of a variety of inflammatory disease processes. The compositions generally comprise at least one edible or medicinal mushroom or extract thereof, at least one cannabinoid, at least one terpene, a curcumoinoid, and at least one flavonoid. Methods for optimizing compositions using artificial intelligence algorithms are also provided.

Compositions and methods are provided for the treatment of a variety of cancers. The compositions generally comprise at least one edible or medicinal mushroom or extract thereof, at least one cannabinoid, at least one terpene, and at least one flavonoid. Methods for optimizing compositions using artificial intelligence algorithms are also provided.